FY22 Clinical Trial Award
The list of Fiscal Year 2022 Ovarian Cancer Research Program Clinical Trial Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
|Health Research, Inc., Roswell Park Division||Emese Zsiros|
|TILT Biotherapeutics Oy||Akseli Hemminki|
Last updated Sunday, December 31, 1600